When should I recheck kidney function in a 60‑year‑old woman with acute decline in renal function (creatinine 1.37 mg/dL, eGFR 44 mL/min/1.73 m²) and hyperkalaemia?

Recheck Kidney Function Within 24-48 Hours (STAT Repeat Today, Then Close Follow-Up)

You need a STAT repeat BMP today to confirm the acute kidney injury and hyperkalemia, followed by reassessment within 24-48 hours after addressing reversible factors, with ongoing monitoring frequency determined by the trajectory of renal recovery.

Immediate Action (Today)

• STAT repeat BMP to confirm creatinine 1.37/eGFR 44 and potassium 5.9 1
• ECG if potassium confirmed ≥5.5 mmol/L to assess for cardiac effects, even if asymptomatic 2
• Medication reconciliation immediately: Hold lisinopril-HCTZ and metformin given AKI/hyperkalemia 3
• Confirm NSAID discontinuation (naproxen, indomethacin) - these are likely culprits for the acute decline

Short-Term Monitoring (First Week)

Recheck within 24-48 hours after initial interventions, then:

• If creatinine improving: Recheck every 2-3 days until stable or back to baseline
• If creatinine stable or worsening: Daily monitoring until trajectory clear 4, 5
• Potassium monitoring parallels renal function checks - critical given K+ 5.9 1

The KDIGO guidelines emphasize that in AKI, monitoring frequency must be individualized based on clinical course 4. With acute decline from eGFR 95-100+ to 44, this represents Stage 2-3 AKI requiring close surveillance.

Ongoing Monitoring After Stabilization

Once renal function stabilizes or begins recovering:

• Weekly for first month after acute episode 5
• Then every 2-4 weeks until return to baseline or new steady state established
• Minimum every 3 months once stable, given she now has demonstrated AKI risk 6

Frequency Algorithm Based on eGFR

The 2018 European guidelines provide a practical rule: Monitor at least every X months, where X = CrCl ÷ 10 7. For her current eGFR 44:

• 44 ÷ 10 = approximately every 4-5 months minimum once stable
• However, given recent AKI, diabetes (A1c 7.4), and hyperkalemia, monthly for 3 months is more appropriate initially 3, 8

Critical Considerations for This Patient

Hyperkalemia Management

With K+ 5.9 mmol/L and eGFR 44, she's at high risk 1:

• Hold ACE-I/ARB (lisinopril) until K+ <5.0 and renal function stabilizes 1
• Consider potassium binder if K+ remains >5.5 after acute interventions 8
• Dietary potassium restriction counseling 1

Metformin Adjustment

Stop metformin immediately with eGFR 44 3:

• Metformin contraindicated with eGFR <45 in unstable AKI
• Can restart at half dose only when eGFR stable ≥45 for at least 2 weeks 3
• If eGFR remains 30-44 after stabilization, use half dose with close monitoring 3

Metabolic Acidosis

CO2 decreased to 18 mmol/L - this requires attention 1:

• Recheck with each BMP
• Consider bicarbonate supplementation if persistently <18 1
• Acidosis worsens hyperkalemia

Red Flags Requiring More Urgent Reassessment

• K+ >6.0 mmol/L on repeat
• Creatinine continues rising >25% from current value
• Urine output decreases significantly
• Development of uremic symptoms (worsening nausea, confusion, pericardial friction rub)
• CO2 drops further below 18

Common Pitfalls to Avoid

1. Don't use eGFR equations in acute settings - follow absolute creatinine trends 4
2. Don't restart ACE-I/ARB too quickly - wait until K+ <5.0 and creatinine stable ×2 weeks 1
3. Don't assume normal ECG means safe potassium - severe hyperkalemia can present without ECG changes 2
4. Don't forget volume status assessment - creatinine concentration affected by hydration 4

Long-Term Plan After Recovery

• If returns to baseline eGFR >90: Annual monitoring acceptable 6
• If stabilizes at eGFR 45-59 (CKD 3a): Every 3-4 months 6, 7
• If remains <45 (CKD 3b): Every 2-3 months given diabetes and hyperkalemia risk 6, 7
• Nephrology referral if doesn't return to near-baseline or if progressive decline 6